[1]
J. S. Gimbel, MD, “Effects of naltrexone exposure observed in two phase three studies with ALO-02, an extended-release oxycodone surrounding sequestered naltrexone”, J of Opioid Management, vol. 15, no. 5, pp. 417–427, Sep. 2019.